BSEM — BIOSTEM TECHNOLOGIES
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1658678 ·
Last close
$3.91
Market Cap
$66.41M
52W High
$6.09
52W Low
$3.90
ADV30
66,188
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 10,473,402 | 9,268,608 | 1,448,790 | 761,052 | 62,392,843 | 27,158,117 | 12,376,434 |
| Dec 2024 | 102,874,353 | 99,339,786 | 8,481,578 | 15,520,498 | 140,375,727 | 22,832,706 | 99,500,195 |
| Sep 2024 | 18,412,816 | 14,174,158 | 9,291,838 | 6,819,902 | 104,200,464 | 14,613,488 | 81,369,253 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$8,159,468
Investing CF
$-131,331
Financing CF
$191,081
CapEx
$-131,331
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$0.35
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,060,009
Inventory
$2,728,981
Receivables
$20,104,929
ST Investments
—
EBIT TTM
$19,224,703
Pretax Income TTM
$19,039,603
Interest Exp TTM
$204,229
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$37,650,524
EBITDA
$-14,106,755
Free Cash Flow
—
Enterprise Value
$59,805,428
Total Cash
$13,703,351
Total Debt
$3,279,704
Shares Out
16,984,057
Trailing EPS
$0.88
Book Value
$1.88
ROE
-48.6%
ROA
-9.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 301,827,302 | 31,200,641 | 31,884,321 | 140,375,727 | 99,500,195 | — | 24,476,653 |
| Dec 2023 | 16,685,405 | -7,778,969 | -8,482,984 | 14,560,291 | 15,904,667 | — | -3,498,960 |
| Dec 2022 | 6,875,202 | -4,681,548 | -7,192,949 | 3,466,433 | 7,416,385 | — | 303,575 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.29
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IMA | ImageneBio, Inc. | $65.64M | $5.82 | — |
| TCRX | TScan Therapeutics, Inc. | $65.35M | $1.07 | — |
| ENTX | Entera Bio Ltd. | $59.56M | $1.21 | — |
| SGMO | SANGAMO THERAPEUTICS, INC | $76.68M | $0.19 | — |
| TIL | Instil Bio, Inc. | $55.07M | $8.12 | — |
News headlines (Yahoo Finance, 1h cache)
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
2026-05-22 11:00 · Yahoo
BioStem Technologies Q1 Earnings Call Highlights
2026-05-16 03:06 · Yahoo
BioStem Technologies Inc (BSEM) Q1 2026 Earnings Call Highlights: Strategic Acquisition and ...
2026-05-15 05:03 · Yahoo
BioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue Estimates
2026-05-14 21:50 · Yahoo
BioStem Technologies Reports First Quarter 2026 Financial Results
2026-05-14 20:05 · Yahoo
Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates
2026-05-13 21:35 · Yahoo
BioStem Technologies to Present at the 16th Annual LD Micro Invitational
2026-05-12 20:05 · Yahoo
BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026
2026-04-30 20:05 · Yahoo
BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer
2026-04-30 11:00 · Yahoo
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
2026-04-08 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.